Skip to content
10-Q

Quarterly Report

AUTOLUS THERAPEUTICS PLC AUTL

0001730463-25-000039

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 7, 2025 266.14M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $66.62M
Current Liabilities Q1 2025 · Dec 31, 2024 $60.74M
Total Liabilities Q1 2025 · Mar 31, 2025 $375.23M
Total Liabilities Q1 2025 · Dec 31, 2024 $355.4M
Current Assets Q1 2025 · Mar 31, 2025 $615.77M
Current Assets Q1 2025 · Dec 31, 2024 $660.93M
Total Assets Q1 2025 · Mar 31, 2025 $746.34M
Total Assets Q1 2025 · Dec 31, 2024 $782.73M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $227.38M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $758.53M
Shares Diluted Q1 2025 · Mar 31, 2024 222.17M sh
Capex Q1 2025 · Mar 31, 2024 $533K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$40.51M
Stockholders Equity Q1 2025 · Mar 31, 2024 $582.03M
Stockholders Equity Q1 2025 · Dec 31, 2023 $111.47M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.24
Eps Basic Q1 2025 · Mar 31, 2024 −$0.24
Sga Expense Q1 2025 · Mar 31, 2024 $18.18M
Rd Expense Q1 2025 · Mar 31, 2024 $30.67M
Net Income Q1 2025 · Mar 31, 2024 −$52.69M
Operating Income Q1 2025 · Mar 31, 2024 −$38.76M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $0